These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29882484)

  • 1. Soluble Cripto-1 Induces Accumulation of Supernumerary Centrosomes and Formation of Aberrant Mitoses in Human Embryonic Stem Cells.
    Porokh V; Vaňhara P; Bárta T; Jurečková L; Bohačiaková D; Pospíšilová V; Mináriková D; Holubcová Z; Pelková V; Souček K; Hampl A
    Stem Cells Dev; 2018 Aug; 27(16):1077-1084. PubMed ID: 29882484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human embryonic stem cells suffer from centrosomal amplification.
    Holubcová Z; Matula P; Sedláčková M; Vinarský V; Doležalová D; Bárta T; Dvořák P; Hampl A
    Stem Cells; 2011 Jan; 29(1):46-56. PubMed ID: 20960514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivo.
    Spike BT; Kelber JA; Booker E; Kalathur M; Rodewald R; Lipianskaya J; La J; He M; Wright T; Klemke R; Wahl GM; Gray PC
    Stem Cell Reports; 2014 Apr; 2(4):427-39. PubMed ID: 24749068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
    Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
    J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2A regulates neural ectoderm fate specification in human embryonic stem cells.
    Yi S; Huang X; Zhou S; Zhou Y; Anderson MK; Zúñiga-Pflücker JC; Luan Q; Li Y
    Development; 2020 Dec; 147(23):. PubMed ID: 33144398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
    Miharada K; Karlsson G; Rehn M; Rörby E; Siva K; Cammenga J; Karlsson S
    Ann N Y Acad Sci; 2012 Aug; 1266():55-62. PubMed ID: 22901256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto-1 modulates macrophage cytokine secretion and phagocytic activity via NF-κB signaling.
    Zhang DM; Bao YL; Yu CL; Wang YM; Song ZB
    Immunol Res; 2016 Feb; 64(1):104-14. PubMed ID: 26476731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of the embryonic gene Cripto-1 is regulated by OCT4 in human embryonal carcinoma NCCIT cells.
    Park SW; Do HJ; Han MH; Choi W; Kim JH
    FEBS Lett; 2018 Jan; 592(1):24-35. PubMed ID: 29223130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants modulating CRIPTO serum levels identified by genome-wide association study in Cilento isolates.
    Ruggiero D; Nappo S; Nutile T; Sorice R; Talotta F; Giorgio E; Bellenguez C; Leutenegger AL; Liguori GL; Ciullo M
    PLoS Genet; 2015 Jan; 11(1):e1004976. PubMed ID: 25629528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model.
    Alam MJ; Takahashi R; Afify SM; Oo AKK; Kumon K; Nawara HM; Khayrani AC; Du J; Zahra MH; Seno A; Salomon DS; Seno M
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30373174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrosomes and cancer: how cancer cells divide with too many centrosomes.
    Godinho SA; Kwon M; Pellman D
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):85-98. PubMed ID: 19156503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities in centrosome number in human embryos and embryonic stem cells.
    Gu YF; OuYang Q; Dai C; Lu CF; Lin G; Gong F; Lu GX
    Mol Reprod Dev; 2016 May; 83(5):392-404. PubMed ID: 26946049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of small bicyclic peptide inhibitors of Cripto-1 activity.
    Iaccarino E; Calvanese L; Untiveros G; Falcigno L; D'Auria G; Latino D; Sivaccumar JP; Strizzi L; Ruvo M; Sandomenico A
    Biochem J; 2020 Apr; 477(8):1391-1407. PubMed ID: 32215602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells.
    Wu D; Shi Z; Xu H; Chen R; Xue S; Sun X
    J Biosci; 2017 Sep; 42(3):405-416. PubMed ID: 29358554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth.
    Ishii H; Zahra MH; Takayanagi A; Seno M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto-1 in TNBC.
    Castro NP; Salomon DS
    Aging (Albany NY); 2015 Aug; 7(8):515-6. PubMed ID: 26298547
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfection with a CRIPTO anti-sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line.
    Baldassarre G; Bianco C; Tortora G; Ruggiero A; Moasser M; Dmitrovsky E; Bianco AR; Ciardiello F
    Int J Cancer; 1996 May; 66(4):538-43. PubMed ID: 8635871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snail-mediated Cripto-1 repression regulates the cell cycle and epithelial-mesenchymal transition-related gene expression.
    Pilli VS; Gupta K; Kotha BP; Aradhyam GK
    FEBS Lett; 2015 May; 589(11):1249-56. PubMed ID: 25889638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
    Gray PC; Shani G; Aung K; Kelber J; Vale W
    Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.